Prescript peritoneal dialysis: Patterns of iron prescribing in peritoneal dialysis
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · 2025
DOI: 10.1177/08968608251335554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2025. Verfasst von Sebastian Spencer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Science, University of Hull, Hull, UK. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Practice Patterns, Physicians', Anemia, Iron-Deficiency, Iron. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Iron deficiency and anaemia are prevalent in people undergoing peritoneal dialysis (PD), necessitating effective iron supplementation. While oral iron is often preferred for its accessibility and cost, it may be insufficient or poorly tolerated. Intravenous (IV) iron is generally well tolerated and associated with improved haemoglobin response and reduced erythropoiesis-stimulating agent requirements, yet optimal dosing, administration intervals, and haematological targets remain under-researched, particularly in PD populations. Current prescribing practices vary significantly, reflecting gaps in evidence and consensus. This study aimed to evaluate UK clinical practices for iron therapy in PD and estimate patient eligibility for a future randomised controlled trial (RCT).
Methods
A cross-sectional survey was conducted among UK-based kidney clinicians using a structured 9-item questionnaire distributed electronically via the UK Kidney Association. The survey explored iron repletion strategies, diagnostic thresholds, and circumstances for withholding therapy. Responses were analysed using descriptive statistics for quantitative data and thematic analysis for free-text responses.
Results
A total of 41 clinicians from 23 dialysis units participated, including consultants (73.2%), registrars (17.1%), and specialist nurses (9.7%). High-dose IV iron (≥500 mg per visit) was the preferred strategy for 65.9% of respondents, while none used oral iron alone. Most clinicians initiated iron therapy when serum ferritin was
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Science, University of Hull, Hull, UK.
- Department of Medical Science, Hull York Medical School, Hull, UK.
- Academic Renal Department, Hull University Teaching Hospitals NHS Trust, Hull, UK.
ORCID-Profile: Sebastian Spencer
Zitieren
APA
Spencer, S., Hunter, S., & Bhandari, S. (2025). Prescript peritoneal dialysis: Patterns of iron prescribing in peritoneal dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. https://doi.org/10.1177/08968608251335554
Vancouver
Spencer S, Hunter S, Bhandari S. Prescript peritoneal dialysis: Patterns of iron prescribing in peritoneal dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 2025. doi:10.1177/08968608251335554
BibTeX
@article{Spencer2025,
author = {Spencer, Sebastian and Hunter, Samantha and Bhandari, Sunil},
title = {Prescript peritoneal dialysis: Patterns of iron prescribing in peritoneal dialysis},
journal = {Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis},
year = {2025},
doi = {10.1177/08968608251335554}
}
EUVIMED